China · Delayed Price · Currency is CNY Walvax Biotechnology Statistics
Total Valuation
SHE:300142 has a market cap or net worth of CNY 18.36 billion. The enterprise value is 17.38 billion.
| Market Cap | 18.36B |
| Enterprise Value | 17.38B |
Important Dates
The next estimated earnings date is Wednesday, August 27, 2025.
| Earnings Date | Aug 27, 2025 |
| Ex-Dividend Date | May 28, 2025 |
Share Statistics
SHE:300142 has 1.60 billion shares outstanding. The number of shares has decreased by -0.89% in one year.
| Current Share Class | 1.60B |
| Shares Outstanding | 1.60B |
| Shares Change (YoY) | -0.89% |
| Shares Change (QoQ) | -2.63% |
| Owned by Insiders (%) | 8.98% |
| Owned by Institutions (%) | 15.27% |
| Float | 1.41B |
Valuation Ratios
The trailing PE ratio is 139.41 and the forward PE ratio is 48.34.
| PE Ratio | 139.41 |
| Forward PE | 48.34 |
| PS Ratio | 6.84 |
| PB Ratio | 1.60 |
| P/TBV Ratio | 2.19 |
| P/FCF Ratio | 37.97 |
| P/OCF Ratio | 19.32 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 56.69, with an EV/FCF ratio of 35.95.
| EV / Earnings | 133.00 |
| EV / Sales | 6.48 |
| EV / EBITDA | 56.69 |
| EV / EBIT | n/a |
| EV / FCF | 35.95 |
Financial Position
The company has a current ratio of 3.27, with a Debt / Equity ratio of 0.04.
| Current Ratio | 3.27 |
| Quick Ratio | 2.90 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 1.53 |
| Debt / FCF | 0.97 |
| Interest Coverage | -18.38 |
Financial Efficiency
Return on equity (ROE) is 1.02% and return on invested capital (ROIC) is -0.52%.
| Return on Equity (ROE) | 1.02% |
| Return on Assets (ROA) | -0.42% |
| Return on Invested Capital (ROIC) | -0.52% |
| Return on Capital Employed (ROCE) | -0.81% |
| Revenue Per Employee | 1.12M |
| Profits Per Employee | 54,723 |
| Employee Count | 2,388 |
| Asset Turnover | 0.18 |
| Inventory Turnover | 0.84 |
Taxes
| Income Tax | -3.92M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +1.65% in the last 52 weeks. The beta is 0.68, so SHE:300142's price volatility has been lower than the market average.
| Beta (5Y) | 0.68 |
| 52-Week Price Change | +1.65% |
| 50-Day Moving Average | 10.81 |
| 200-Day Moving Average | 12.21 |
| Relative Strength Index (RSI) | 65.30 |
| Average Volume (20 Days) | 38,502,129 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300142 had revenue of CNY 2.68 billion and earned 130.68 million in profits. Earnings per share was 0.08.
| Revenue | 2.68B |
| Gross Profit | 1.93B |
| Operating Income | -100.10M |
| Pretax Income | 112.48M |
| Net Income | 130.68M |
| EBITDA | 281.89M |
| EBIT | -100.10M |
| Earnings Per Share (EPS) | 0.08 |
Balance Sheet
The company has 3.50 billion in cash and 469.32 million in debt, giving a net cash position of 3.04 billion or 1.90 per share.
| Cash & Cash Equivalents | 3.50B |
| Total Debt | 469.32M |
| Net Cash | 3.04B |
| Net Cash Per Share | 1.90 |
| Equity (Book Value) | 11.49B |
| Book Value Per Share | 5.90 |
| Working Capital | 4.69B |
Cash Flow
In the last 12 months, operating cash flow was 950.44 million and capital expenditures -466.93 million, giving a free cash flow of 483.52 million.
| Operating Cash Flow | 950.44M |
| Capital Expenditures | -466.93M |
| Free Cash Flow | 483.52M |
| FCF Per Share | 0.30 |
Margins
Gross margin is 71.73%, with operating and profit margins of -3.73% and 4.87%.
| Gross Margin | 71.73% |
| Operating Margin | -3.73% |
| Pretax Margin | 4.19% |
| Profit Margin | 4.87% |
| EBITDA Margin | 10.50% |
| EBIT Margin | -3.73% |
| FCF Margin | 18.02% |
Dividends & Yields
This stock pays an annual dividend of 0.01, which amounts to a dividend yield of 0.09%.
| Dividend Per Share | 0.01 |
| Dividend Yield | 0.09% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 32.70% |
| Buyback Yield | 0.89% |
| Shareholder Yield | 0.97% |
| Earnings Yield | 0.71% |
| FCF Yield | 2.63% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 14, 2015. It was a forward split with a ratio of 3.
| Last Split Date | Oct 14, 2015 |
| Split Type | Forward |
| Split Ratio | 3 |
Scores
SHE:300142 has an Altman Z-Score of 5.11 and a Piotroski F-Score of 5.
| Altman Z-Score | 5.11 |
| Piotroski F-Score | 5 |